Compare RDY & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | BILI |
|---|---|---|
| Founded | 1984 | 2009 |
| Country | India | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 10.8B |
| IPO Year | N/A | 2018 |
| Metric | RDY | BILI |
|---|---|---|
| Price | $13.85 | $31.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $16.90 | ★ $30.00 |
| AVG Volume (30 Days) | 1.8M | ★ 3.7M |
| Earning Date | 01-20-2026 | 02-19-2026 |
| Dividend Yield | ★ 0.53% | N/A |
| EPS Growth | ★ 5.58 | N/A |
| EPS | ★ 0.76 | 0.25 |
| Revenue | $3,848,694,754.00 | ★ $4,180,323,637.00 |
| Revenue This Year | $6.12 | $14.70 |
| Revenue Next Year | $2.58 | $9.45 |
| P/E Ratio | ★ $17.93 | $130.58 |
| Revenue Growth | 11.09 | ★ 16.95 |
| 52 Week Low | $12.26 | $14.47 |
| 52 Week High | $16.17 | $36.40 |
| Indicator | RDY | BILI |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 52.85 |
| Support Level | $12.95 | $32.64 |
| Resistance Level | $13.85 | $36.40 |
| Average True Range (ATR) | 0.27 | 1.05 |
| MACD | 0.05 | -0.16 |
| Stochastic Oscillator | 91.20 | 26.68 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.